ASH 48th (2006)

Title Content type
Validation of Serum Aspergillus Galactomannan Index as a Surrogate Endpoint for Outcome of Invasive Aspergillosis: Clinical and Research Implications. (click for details)
Downs Syndrome Patients with Acute Lymphoblastic Leukemia; an Intermediate Outcome with a High Infectious Morbidity. (click for details)
Identification of Off-Patent Drugs That Reverse Daunorubicin Efflux Mediated by ABCB1 in T-ALL Cells. (click for details)
Monitoring of 1,3-Beta-D-Glucan (BGL) Antigenemia in Neutropenic Patients with Acute Leukemia at High Risk for Invasive Fungal Infections (IFI). (click for details)
Breakthrough C. parapsilosis (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem Cell (HSC) Recipients Receiving Long Term Caspofungin (C) Therapy. (click for details)
Positive AML with Favorable Clinical Characteristics, in a Child with Ependymoma after Combined Treatment with Neuroaxis Irradiation and Topoisomerase II Inhibitors. (click for details)
Prospective Evaluation of Procalcitonin in Adults after Prolonged Neutropenia. (click for details)
Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD. (click for details)
Strategy for Managing Patients with Prior Invasive Aspergillosis through Allogeneic Transplant. (click for details)
Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Severe Aplastic Anemia (SAA) above the Age of 40 Years. (click for details)


Subscribe to ASH 48th (2006)